Real-time enrollment status for this cancer-associated thrombosis (cat) clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 2:11 PM UTC
| NCT Number | NCT07410117 |
| Recruiting Status | Recruiting |
| Condition | Cancer-Associated Thrombosis (CAT) |
| Phase | Clinical Trial |
| Target Enrollment | 1,120 participants |
| Active Locations | 3 sites in the US |
| Sponsor | Regeneron Pharmaceuticals |
| Last Updated on CT.gov | May 27, 2026 (May 27, 2026) |
As of July 13, 2026: Clinical trial NCT07410117 is currently recruiting participants. This clinical trial study for cancer-associated thrombosis (cat) is actively seeking new participants at 3 locations across the United States. The study is sponsored by Regeneron Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07410117 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 3 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07410117 was last updated May 27, 2026 (May 27, 2026). HelloStudys verifies this status automatically.